Literature DB >> 15460444

Ginsenoside Rh2 induces apoptosis via activation of caspase-1 and -3 and up-regulation of Bax in human neuroblastoma.

Young-Sook Kim1, Sung-Ha Jin.   

Abstract

In human neuroblastoma SK-N-BE(2) cells undergoing apoptotic death induced by ginsenoside Rh2, a dammarane glycoside that was isolated from Panax ginseng C. A. Meyer, caspase-1 and caspase-3 were activated. The expression of Bax was increased in the cells treated with ginsenoside Rh2, whereas Bcl-2 expression was not altered. Treatment with caspase-1 inhibitor, Ac-YVAD-CMK, or caspase-3 inhibitor, Z-DEVD-FMK, partially inhibited ginsenoside Rh2-induced cell death but almost suppressed the cleavage of the 116 kDa PARP into a 85 kDa fragment. When the levels of p53 were examined in this process, p53 accumulated rapidly in the cells treated early with ginsenoside Rh2. These results suggest that activation of caspase-1 and -3 and the up-regulation of Bax are required in order for apoptotic death of SK-N-BE(2) cells to be induced by ginsenoside Rh2, and p53 plays an important role in the pathways to promote apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15460444     DOI: 10.1007/BF02980175

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  9 in total

1.  Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of Akt.

Authors:  E-K Park; E J Lee; S-H Lee; K H Koo; J Y Sung; E H Hwang; J H Park; C-W Kim; K-C Jeong; B-K Park; Y-N Kim
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128.

Authors:  Nan Wu; Guo-cai Wu; Rong Hu; Mei Li; Hua Feng
Journal:  Acta Pharmacol Sin       Date:  2011-03       Impact factor: 6.150

3.  Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases.

Authors:  Sunga Choi; Tae Woong Kim; Shivendra V Singh
Journal:  Pharm Res       Date:  2009-07-23       Impact factor: 4.200

Review 4.  Current evaluation of the millennium phytomedicine- ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine.

Authors:  Lee Jia; Yuqing Zhao; Xing-Jie Liang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

5.  Antiproliferative Activity of Combined Biochanin A and Ginsenoside Rh₂ on MDA-MB-231 and MCF-7 Human Breast Cancer Cells.

Authors:  Guixing Ren; Zhenxing Shi; Cong Teng; Yang Yao
Journal:  Molecules       Date:  2018-11-08       Impact factor: 4.411

Review 6.  Saponins from Chinese Medicines as Anticancer Agents.

Authors:  Xiao-Huang Xu; Ting Li; Chi Man Vivienne Fong; Xiuping Chen; Xiao-Jia Chen; Yi-Tao Wang; Ming-Qing Huang; Jin-Jian Lu
Journal:  Molecules       Date:  2016-10-05       Impact factor: 4.411

7.  Anti-Cancer Effect of Ginsenoside F2 against Glioblastoma Multiforme in Xenograft Model in SD Rats.

Authors:  Ji Yon Shin; Jung Min Lee; Heon Sub Shin; Sang Yong Park; Jung Eun Yang; Somi Kim Cho; Tae-Hoo Yi
Journal:  J Ginseng Res       Date:  2012-01       Impact factor: 6.060

8.  AMP-activated protein kinase determines apoptotic sensitivity of cancer cells to ginsenoside-Rh2.

Authors:  Min-Jung Kim; Hee Yun; Dong-Hyun Kim; Insug Kang; Wonchae Choe; Sung-Soo Kim; Joohun Ha
Journal:  J Ginseng Res       Date:  2013-12-08       Impact factor: 6.060

9.  p53-dependent Fas expression is critical for Ginsenoside Rh2 triggered caspase-8 activation in HeLa cells.

Authors:  Xiao-Xi Guo; Yang Li; Chao Sun; Dan Jiang; Ying-Jia Lin; Feng-Xie Jin; Seung-Ki Lee; Ying-Hua Jin
Journal:  Protein Cell       Date:  2014-03-13       Impact factor: 14.870

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.